Scientists enhance eye imaging with AI, achieving high-resolution views of retinal cells, potentially revolutionizing disease ...

Tyrosine Kinase Inhibitors to Prolong Efficacy of Anti-VEGF Therapies ...

Topcon Healthcare has appointed Daniela Ferrara, MD, PhD, as chief medical officer to lead the company’s clinical and medical strategy. Daniela Ferrara, MD, PhD, is stepping into the role of chief ...

Brazilian researchers used swept-source OCT and OCT-angiography to study the effects of an initial dose of aflibercept on untreated diabetic macular edema in patients. Brazilian researchers led by ...

The Embedded Behavioral Health Service is described as a “unique and innovative psychology service” in the Ophthalmology Department at the Massachusetts Eye and Ear (MEEI), Boston, in collaboration ...

UBX1325 is a novel BCL-xL inhibitor designed to eliminate senescent cells in diabetic retinal blood vessels, while leaving healthy ones intact.

Tyrosine Kinase Inhibitors to Prolong Efficacy of Anti-VEGF Therapies ...

Tyrosine Kinase Inhibitors to Prolong Efficacy of Anti-VEGF Therapies ...

Brazilian researchers used swept-source OCT and OCT-angiography to study the effects of an initial dose of aflibercept on untreated diabetic macular edema in patients.

Tyrosine Kinase Inhibitors to Prolong Efficacy of Anti-VEGF Therapies ...

By isolating and focusing on stimulating only the M cells on the retina, they created a new color signal that the human eye ...